Search
NeOnc Technologies Holdings Inc
NTHIAdd to Watchlist
4.420USD
-0.040-0.90%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
114.62MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of NeOnc Technologies Holdings Inc is 8.67, ranking 75 out of 387 in the Biotechnology & Medical Research industry.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
16.000
Target Price
+261.17%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
NeOnc Technologies Holdings Inc
NTHI
3
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have NeOnc Technologies Holdings IncNTHI's recent earnings per share performed?
The market expectation was USD -0.38, while NeOnc Technologies Holdings IncNTHI's earnings per share (EPS) for the previous quarter was USD -0.73. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for NeOnc Technologies Holdings Inc?
Based on the ratings of NeOnc Technologies Holdings Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.